Oxford Finance closed a senior credit facility with Diversis Capital, a private equity firm focused on acquiring and growing small- and middle-market companies. Oxford was the sole lender and administrative agent for this transaction.

Funds were used to acquire Caligor Rx, a provider of comparator drugs for clinical trials.

“Oxford is very pleased that Diversis chose Oxford to finance its first acquisition in the healthcare space,” said Tracy S. Maziek, managing director at Oxford Finance. “Caligor plays an important role in the supply chain that delivers innovative and critical drugs to the market, and we wish Diversis success with this new business venture.”

Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies worldwide.